Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy

被引:90
作者
Evers, IM
van der Schoot, B
ter Braak, EWMT
Janssen, N
de Valk, HW
Visser, GHA
机构
[1] Univ Utrecht, Univ Med Ctr Urecht, Dept Obstet, NL-3508 AB Utrecht, Netherlands
[2] Univ Utrecht, Univ Med Ctr, Dept Internal Med & Endocrinol, NL-3508 AB Utrecht, Netherlands
[3] Univ Utrecht, Univ Med Ctr, Sch Med, NL-3508 AB Utrecht, Netherlands
关键词
D O I
10.2337/diacare.25.3.554
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES- To investigate the frequency of severe hypoglycemia (SH) and hypoglycemic coma during the first trimester of type 1 diabetic pregnancy and in the 4 months before gestation and to identify risk indicators predicting first trimester SH in a nonselected nationwide cohort of pregnant women with type 1 diabetes. RESEARCH DESIGN AND METHODS - We conducted a longitudinal cohort survey in 278 pregnant type 1 diabetic women using questionnaires at inclusion and at 17 weeks of addressing the frequencies of SH (i.e., external help required) and hypoglycemic coma, general characteristics, hypoglycemia awareness, blood glucose symptom threshold, and the Hypoglycemia Fear Survey. RESULTS - The occurrence of SH (including hypoglycemic coma) rose from 0.9 +/- 2.4 episodes per 4 months before gestation to 16 +/- 6.3 episodes during the first trimester (P < 0.001, including an increase in episodes of coma from 0.3 +/- 1.3 to 0.7 +/- 3.7 (P = 0.03). The proportion of women affected by SH rose from 25 to 41% (P < 0.001). First-trimester SH was independently related to a history of SH before gestation (odds ratio [95%CI]: 9.2 [3.9-21.7]), a 10 years' longer diabetes duration 1.6 [1.0-2.4]), an HbA(1c) level less than or equal to6.5% (2.5 [1.3-5.0]), and a 0.1 unit/kg higher daily insulin dose (5.4 [1.5-18.9]), adjusted for a decreased symptom threshold. CONCLUSIONS - In type 1 diabetic pregnancy, the risk of SH is increased already before pregnancy and rises further during the first trimester. A history of SH before gestation, longer duration of diabetes, an HbA(1c) level less than or equal to6.5%, and a higher total daily insulin dose were risk indicators predictive for SH during the first trimester Further research should aim to elucidate how the benefits of strict glycemic control balance with the markedly, increased risk of SH early in pregnancy.
引用
收藏
页码:554 / 559
页数:6
相关论文
共 30 条
[1]   EFFECT OF INTENSIVE INSULIN THERAPY ON GLYCEMIC THRESHOLDS FOR COUNTERREGULATORY HORMONE-RELEASE [J].
AMIEL, SA ;
SHERWIN, RS ;
SIMONSON, DC ;
TAMBORLANE, WV .
DIABETES, 1988, 37 (07) :901-907
[2]   Hormonal counterregulation and subjective symptoms during induced hypoglycemia in insulin-dependent diabetes mellitus patients during and after pregnancy [J].
Bjorklund, A ;
Adamson, U ;
Andreasson, K ;
Carlstrom, K ;
Hennen, G ;
Igout, A ;
Lins, PE ;
Westgren, M .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1998, 77 (06) :625-634
[3]   EMBRYOTOXIC EFFECTS OF BRIEF MATERNAL INSULIN-HYPOGLYCEMIA DURING ORGANOGENESIS IN THE RAT [J].
BUCHANAN, TA ;
SCHEMMER, JK ;
FREINKEL, N .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (03) :643-649
[4]   MULTIFACTORIAL ORIGIN OF HYPOGLYCEMIC SYMPTOM UNAWARENESS IN IDDM - ASSOCIATION WITH DEFECTIVE GLUCOSE COUNTERREGULATION AND BETTER GLYCEMIC CONTROL [J].
CLARKE, WL ;
GONDERFREDERICK, LA ;
RICHARDS, FE ;
CRYER, PE .
DIABETES, 1991, 40 (06) :680-685
[5]   REDUCED AWARENESS OF HYPOGLYCEMIA IN ADULTS WITH IDDM - A PROSPECTIVE-STUDY OF HYPOGLYCEMIC FREQUENCY AND ASSOCIATED SYMPTOMS [J].
CLARKE, WL ;
COX, DJ ;
GONDERFREDERICK, LA ;
JULIAN, D ;
SCHLUNDT, D ;
POLONSKY, W .
DIABETES CARE, 1995, 18 (04) :517-522
[6]   Biopsychobehavioral model of severe hypoglycemia II - Understanding the risk of severe hypoglycemia [J].
Cox, DJ ;
Gonder-Frederick, LA ;
Kovatchev, BP ;
Young-Hyman, DL ;
Donner, TW ;
Julian, DM ;
Clarke, WL .
DIABETES CARE, 1999, 22 (12) :2018-2025
[7]   FEAR OF HYPOGLYCEMIA - QUANTIFICATION, VALIDATION, AND UTILIZATION [J].
COX, DJ ;
IRVINE, A ;
GONDERFREDERICK, L ;
NOWACEK, G ;
BUTTERFIELD, J .
DIABETES CARE, 1987, 10 (05) :617-621
[8]  
Cryer PE, 1999, DIABETES-METAB RES, V15, P42, DOI 10.1002/(SICI)1520-7560(199901/02)15:1<42::AID-DMRR1>3.0.CO
[9]  
2-B
[10]  
DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z